Coronavirus Update: Moderna’s Vaccine Shows Signs Of Lasting Protection
Plus: Pfizer CEO Relaxed About Vaccine Logistics
Executive Summary
The US is to ship only half of doses for Pfizer, Moderna COVID-19 vaccines in the first instance, while Rhizen Pharmaceuticals starts a Phase I trial of a DHODH inhibitor.